The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults — PIP

Intestinal Barrier Function Clinical Trial

Official title:
The Effect of Probiotic Intake on Intestinal Permeability of Healthy Adults

Status Completed

Clinical Trial Summary

In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked to provide urine and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the probiotic.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Intestinal Barrier Function

Clinical Trial Details

NCT number	NCT03611400
Study type	Interventional
Source	University of Florida
Contact
Status	Completed
Phase	N/A
Start date	August 22, 2018
Completion date	April 15, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01686204` - Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt	N/A
	Completed	`NCT03744221` - Health Effects of Sustainable Future Proteins	N/A